Little-known makers of generic drugs played central role in opioid crisis, records show
Douglas S. Boothe was the leader of a little-known generic-drug maker seven years ago when federal agents approached his company with an urgent plea: Slash production of an addictive pain medication that was fueling a national crisis.
Boothe wasnt interested and rejected the Drug Enforcement Administrations request that Actavis voluntarily cut its supply of oxycodone to U.S. pharmacies, according to exhibits unsealed recently in a landmark lawsuit that accuses drug companies of recklessly distributing billions of addictive pain pills despite glaring signs of abuse.
Now, Boothe is among a crop of figures from the generic-drug industry from high-ranking executives to salesmen to account managers whose decisions during the height of the countrys opioid epidemic have been thrust into the national spotlight after the release of the documents.
Drugmaker Purdue Pharma and its owners, the Sackler family, have for years borne the brunt of public criticism for inventing and deceptively marketing one of the most well-known opioid painkillers, OxyContin, in the 1990s. But the records show that by 2006, as the death rate accelerated, a handful of obscure generic-drug manufacturers were selling the bulk of opioid pills flooding the country.
-more-
https://www.msn.com/en-us/news/us/little-known-makers-of-generic-drugs-played-central-role-in-opioid-crisis-records-show/ar-AAEWWlb?li=BBnbfcL